Showing results (81-90 of 171) with videos related to
Sort By:
Pageof 18
Cancer|June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancerKenneth H Yu, Jennifer Park, Avni Mittal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 9, 2011
Modern approaches to localized cancer of the esophagusRobert E Glasgow, David H Ilson, James A Hayman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinomaManish A Shah, Minaxi Jhawer, David H Ilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapyBaruch Brenner, David H Ilson, Bruce D Minsky, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 19, 2024
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical ManagementMatthew R Strickland, Eric M Lander, Michael K Gibson, et al.The Journal of Thoracic and Cardiovascular Surgery|January 24, 2021
Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancerSmita Sihag, Geoffrey Y Ku, Kay See Tan, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric CancerHenry S Walch, Raktim Borpatragohain, Justin Jee, et al.Pageof 18